Mitochondrial DNA and traumatic brain injury

Area of Science:

• Neuroscience
• Genetics
• Pathophysiology

Background:

• Traumatic brain injury (TBI) presents significant interindividual outcome variability.
• Mitochondria, with their own DNA (mtDNA), play a crucial role in neurological injury.
• mtDNA variants may contribute to differing TBI susceptibility and recovery.

Purpose of the Study:

• To investigate the association between mitochondrial haplogroups and TBI outcomes.
• To explore potential interactions between mtDNA, age, and APOE genotype in TBI patients.

Main Methods:

• Analysis of mitochondrial haplogroups in 1,094 TBI patients.
• Application of a proportional odds model to Glasgow Outcome Score (GOS) data.
• Inclusion of covariates: age, CT characteristics, injury severity, pupillary reactivity, and APOE.

Main Results:

• mtDNA showed a significant association with 6-month GOS (p=0.008).
• Haplogroup K was linked to favorable outcomes (OR=1.64, p=0.02).
• Significant interactions were found between mtDNA and age (p=0.002), and between APOE and mtDNA (p=0.001).
• Haplogroups T and K demonstrated protective effects with advancing age.
• Haplogroup K offered protection in APOE ε4 carriers.

Conclusions:

• Mitochondrial DNA variants, particularly haplogroups K and T, are associated with TBI outcomes.
• These findings highlight an interplay between mtDNA, TBI pathophysiology, and aging.
• APOE pathways interact with genetically determined mitochondrial functions in acute injury response.